Nicotine Pouches, Youth Risk, and the Limits of Alarmist Framing

A GINN Insight responding to recent Medscape coverage Nicotine pouches are increasingly positioned at the centre of a familiar policy tension: how to protect young people from nicotine initiation without undermining harm-reduction pathways for adults who smoke. Recent media coverage, including a Medscape Medical News feature, rightly raises youth-protection concerns but risks misrepresenting the evidence…

Nicotine Pouches Gain Momentum — What Market Signals Are Telling Policymakers

Nicotine pouches are no longer a niche or experimental category. Retail and market indicators now show sustained growth across major U.S. convenience channels, reinforcing a reality that regulators globally can no longer ignore: consumer uptake is happening faster than policy alignment. Recent U.S. retail reporting highlights accelerating sales, expanding shelf presence, and increasing manufacturer investment…

Nicotine Pouches, Switching Behaviour, and What the Evidence Actually Shows

As nicotine pouches gain visibility in multiple markets, debate around their public-health role is intensifying. A recent peer-reviewed study published in JAMA Network Open adds important empirical clarity to that discussion, particularly around who is using nicotine pouches, why they are using them, and what this means for smoking-related harm. Rather than focusing on speculative…